文献速递青光眼

青光眼用药依从性教育干预的试验内成本效果分析

Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma.
PubMed 文献 · Am J Ophthalmol · 2022-08-21

本研究基于随机对照试验数据,在退伍军人事务(VA)眼科门诊评估行为干预对青光眼用药依从性的成本效果。干预组在6个月时依从率高于对照组(0.78 vs 0.40,P<.0001),干预组总成本低于对照组,在100例假设队列中归因成本节约约-149100美元并增加38例依从患者。

要点

  • 6个月时干预组依从率0.78,对照组0.40,差异有统计学意义(P<.0001)。
  • 6个月总成本干预组1149600美元,对照组1298700美元,假设100例队列中归因成本节约约-149100美元。
  • 干预组较对照组增加38例患者达到用药依从,干预有效且节省成本。

核心结论

  • 作者结论认为,增强依从性的行为干预在6个月时有效且节省成本。

研究设计与样本

  • 研究为随机对照试验数据的前瞻性成本效果分析。
  • 研究场所为退伍军人事务(VA)眼科门诊,对象为接受药物治疗且自报依从性差的青光眼退伍军人。
  • 参与者随机接受个性化教育课程联合提醒药瓶以促进用药依从,或接受一般眼健康对照课程。

主要发现

  • 200例随机参与者中,干预组100例中95例、对照组100例中97例在6个月时有依从性结局。
  • 干预组达到依从的患者比例高于对照组(0.78 vs 0.40,P<.0001)。
  • 所有参与者均有6个月成本数据;6个月总成本干预组(n=100)为1149600美元,对照组(n=100)为1298700美元。
  • 在100例患者的假设队列中,干预与成本节约(-149100美元)相关,并使额外38例患者达到用药依从。

关键数值与推荐

  • 依从性以电子监测器测量,主要结局为达到≥80%依从的参与者比例。
  • 成本从VA付款方角度在6个月时使用VA管理成本会计系统评估,采用自助法样本进行概率敏感性分析。

临床怎么用

  • 原文结论指出,增强依从性的行为干预在6个月时有效且节省成本。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the within-trial cost-effectiveness of a behavioral intervention to improve glaucoma medication adherence. DESIGN: Prospective cost-effectiveness analysis of randomized, controlled trial data. METHODS: The study setting was a Veterans Affairs (VA) eye clinic. The patient population comprised veterans with medically treated glaucoma and self-reported poor adherence. Participants were randomized to a personalized educational session with a reminder bottle to promote medication adherence or to a control session on general eye health. Costs were assessed from the perspective of the VA payor at 6 months using the VA Managerial Cost Accounting System. Probabilistic sensitivity analyses were conducted using bootstrapped samples. The main outcome measures were the proportion of participants attaining ≥80% adherence as measured by electronic monitor, total intervention and medical resource costs, and incremental cost-effectiveness ratios comparing intervention to control at 6 months. RESULTS: Of 200 randomized participants, 95 of 100 assigned to the intervention and 97 of 100 assigned to the control had adherence outcomes at 6 months, and the proportion of adherent patients was higher in the intervention group compared to control (0.78 vs 0.40, P < .0001). All participants had costs at 6 months. The total cost at 6 months was $1,149,600 in the intervention group (n = 100) compared to $1,298,700 in the control group (n = 100). Thus, in a hypothetical cohort of 100 patients, the intervention was associated with cost savings (-$149,100) and resulted in 38 additional patients achieving medication adherence. CONCLUSIONS: An adherence-enhancing behavioral intervention was effective and cost saving at 6 months.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Williams AM, Theophanous C, Muir KW, et al. Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma. Am J Ophthalmol. 2022. PMID: 36002073. doi:10.1016/j.ajo.2022.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。